directCHECK ACT-LR whole blood quality control, level 2 Recall
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
FDA recall Class II
Ongoing
FDA lists this Class II recall for directCHECK ACT-LR whole blood quality control, level 2. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2460-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 30, 2026
- FDA report date
- Jun 24, 2026
- Quantity in commerce
- 6060
- Distribution
- See key details
- FDA cause
- Process control
What is being recalled?
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Affected model & UDI checker
Search the exact identifiers published for Z-2460-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| DCGLR-2 | directCHECK ACT-LR whole blood quality control, level 2 | Check source notice | Not specified |
FDA code information
Lot #: A6DLA001 Unique Device Identifier: 10711234170373
Why was this product recalled?
Assayed Whole blood control contains labeling with incorrect performance range.
What actions did Accriva Diagnostics, Inc. take?
On May 8, 2026 Accriva Diagnostics, issued a Urgent Medical Device Recall Notification to affected consignees via E-Mail.. Accriva asked consignees to take the following actions: 1. Please forward this communication to those within your organization who need to become aware 2. Forward the enclosed customer notification to all other organizations where affected devices may have been transferred to. 3. Forward the enclosed customer notification to those in your organization that are responsible for performing quality control testing and/or supervise testing. 4. Please check your inventory to determine if you have any boxes of directCHECK Whole BloodControls. If you have this product in stock, do NOT use. 5. Please destroy all impacted boxes and document on the enclosed form. 6. Please read the instructions on the Tracking Form and complete and return the form to Accriva Diagnostics, Inc. 7. If you have any technical questions, please contact Technical Services at 1-800-678-0710 Option 3 or e-mail [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2460-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology